CorMedix, Inc. (CRMD)
7.69
+0.34
(+4.63%)
USD |
NASDAQ |
Feb 06, 16:00
7.675
-0.02
(-0.20%)
After-Hours: 20:00
CorMedix Market Cap : 605.89M for Feb. 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.412B |
| Pfizer Inc. | 154.76B |
| Arcutis Biotherapeutics, Inc. | 3.346B |
| ANI Pharmaceuticals, Inc. | 1.838B |
| Castle Biosciences, Inc. | 955.93M |
Market Cap Related Metrics
| PE Ratio | 3.746 |
| PS Ratio | 2.589 |
| Price to Book Value | 1.620 |
| Price to Free Cash Flow | 7.456 |
| Price | 7.69 |
| Earnings Yield | 26.70% |
| Operating PE Ratio | 5.338 |
| Normalized PE Ratio | 3.756 |